Cancer research, the topic of the 4th episode of the Arqus Knowledge Pills

21 April2021

Arqus devotes its fourth podcast to cancer research, in an interview with Giovanna Lollo, from the Laboratory of Automatic Control, Chemical and Pharmaceutical Engineering of the Université de Lyon.

How can nanoparticles help our immune system to fight cancer?

This episode is devoted to the design and development of drug delivery nanosystems, namely nanomedicines, for cancer therapy. A promising approach in this field is to engineer nanomedicines to stimulate a specific immune response against cancers.

Note: The vaccines Giovanna refers to are the ones developed by Moderna and BioNTech/Pfizer. In the time that has passed between the recording and the publication of this podcast, those two have gained international recognition as they were among the first authorized vaccines against SARS-CoV-2.

The episodes of the “Arqus Knowledge Pills” are published on a regular basis and can be subscribed to on Spotify, anchor and other platforms (see below). Gerhild Leljak (University of Graz) and Pietro Osti (University of Padua) are the moderators that lead listeners through each episode.

Newsletter

Don’t miss any news, calls or opportunities from Arqus.
Subscribe now! The future begins today.

    Subscribe


    You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us.

    We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

    Controller: University of Granada (as Coordinator of the Arqus European University Alliance). Legal basis: Arqus is entitled to process your data under the provisions of Article 6.1. (a) of the GDPR: “the data subject has given consent to the processing of his or her personal data for one or more specific purposes”. Purpose: to manage your subscription to mailing lists and to periodically send you the requested information by electronic means. Recipients: Mailchimp. Rights: access, object, rectification, erasure, restriction of processing, data portability. Additional information here.

    Select our profile:

    Apart from the general information, what specific news would you like to receive from Arqus?

    Controller: University of Granada (as Coordinator of the Arqus European University Alliance). Legal basis: Arqus is entitled to process your data under the provisions of Article 6.1. (a) of the GDPR: “the data subject has given consent to the processing of his or her personal data for one or more specific purposes”. Purpose: to manage your subscription to mailing lists and to periodically send you the requested information by electronic means. Recipients: Mailchimp. Rights: access, object, rectification, erasure, restriction of processing, data portability. Additional information here.